Professor Gerry McCann

Professor of Cardiac Imaging

Honorary Consultant Cardiologist

Department of Cardiovascular Sciences
University of Leicester
Cardiovascular Research Centre
Glenfield General Hospital
Leicester, LE3 9QP


Tel: +44 (0)116 258 3038

Personal details

I have established a national and growing international reputation as an expert in Cardiac MRI (CMR).

  • BSc (Physiology/Sports Science), University of Glasgow, 1989
  • MB ChB University of Glasgow, 1992
  • MRCP (UK), 1995
  • Dip.Sp.Med., Scottish Royal Colleges, 1997
  • MD University of Glasgow, 2002

External positions

  • BSCMR Board member 2008-2014
  • BSCMR Research Group Co-Chair 2012-present
  • NIHR CRN CV Deputy Lead East Midlands 2014-present
  • NIHR CLRN CV Deputy Lead Leicester, Northampton and Rutland 2012-2014


Alison Watson
Tel: +44 (0)116 258 3038

Imaging Research Manager

Sally Utton
Tel: +44 (0) 116 204 4786



  • Singh A, Chan DCS, Greenwood JP, Dawson DK, Sonecki P, Hogrefe K, Kelly DJ, Dhakshinamurthy V, Lang CC, Khoo JP, Sprigings D, Steeds RP, Zhang R, Ford I, Jerosch-Herold M, Yang J, Li Z, Ng LL, McCann GP. Symptom Onset in Aortic Stenosis: Relation to Sex Differences in Left Ventricular Remodeling. JACC Cardiovasc Imaging. 2019 Jan;12(1):96-105. doi: 10.1016/j.jcmg.2017.09.019. Epub 2017 Dec 13. PMID: 29248646
  • Kanagala P, Cheng ASH, Singh A, Khan JN, Gulsin GS, Patel P, Gupta P, Arnold JR, Squire IB, Ng LL and McCann GP. Relationship Between Focal and Diffuse Fibrosis Assessed by CMR and Clinical Outcomes in Heart Failure with Preserved Ejection Fraction. JACC Cardiovascular imaging. 2019; DOI: 10.1016/j.jcmg.2018.11.031. PMID: 30772227
  • Musa TA, Treibel TA, Vassiliou VS, Captur G, Singh A, Chin C, Dobson LE, Pica S, Loudon M, Malley T, Rigolli M, Foley JRJ, Bijsterveld P, Law GR, Dweck MR, Myerson SG, McCann GP, Prasad SK, Moon JC and Greenwood JP. Myocardial Scar and Mortality in Severe Aortic Stenosis. Circulation. 2018; 138:1935-1947 DOI: 10.1161/CIRCULATIONAHA.117.032839. PMID: 30002099 PMCID: PMC6221382
  • Greenwood JP, Ripley DP, Berry C, McCann GP, Plein S, Bucciarelli-Ducci C, Dall'Armellina E, Prasad A, Bijsterveld P, Foley JR, Mangion K, Sculpher M, Walker S, Everett CC, Cairns DA, Sharples LD, Brown JM; CE-MARC 2 Investigators. Effect of Care Guided by Cardiovascular Magnetic Resonance, Myocardial Perfusion Scintigraphy, or NICE Guidelines on Subsequent Unnecessary Angiography Rates: The CE-MARC 2 Randomized Clinical Trial. JAMA. 2016 Sep 13;316(10):1051-60. doi: 10.1001/jama.2016.12680. PMID: 27570866
  • Nazir SA, McCann GP, Greenwood JP, Kunadian V, Khan JN, Mahmoud IZ, Blackman DJ, Been M, Abrams KR, Shipley L, Wilcox R, Adgey AA, Gershlick AH. Strategies to attenuate micro-vascular obstruction during P-PCI: the randomized reperfusion facilitated by local adjunctive therapy in ST-elevation myocardial infarction trial. Eur Heart J. 2016 Jun 21;37(24):1910-9. PMID: 27147610 PMCID: PMC4917746
  • MacDonald TM, Williams B, Webb DJ, Morant S, Caulfield M, Cruickshank JK, Ford I, Sever P, Mackenzie IS, Padmanabhan S, McCann GP, Salsbury J, McInnes G, Brown MJ; British Hypertension Society Programme of Prevention and Treatment of Hypertension With Algorithm‐based Therapy (PATHWAY). Combination Therapy Is Superior to Sequential Monotherapy for the Initial Treatment of Hypertension: A Double-Blind Randomized Controlled Trial. J Am Heart Assoc. 2017 Nov 18;6(11). pii: e006986. doi: 10.1161/JAHA.117.006986.  PMID: 29151036 PMCID: PMC5721778
  • Kanagala P, Cheng ASH, Singh A, McAdam J, Marsh AM, Arnold JR, Squire IB, Ng LL, McCann GP. Diagnostic and prognostic utility of cardiovascular magnetic resonance imaging in heart failure with preserved ejection fraction - implications for clinical trials. J Cardiovasc Magn Reson. 2018 Jan 11;20(1):4. doi: 10.1186/s12968-017-0424-9. PMID: 29321034
  • Singh A, Greenwood JP, Berry C, Dawson DK, Hogrefe K, Kelly DJ, Dhakshinamurthy V, Lang CC, Khoo JP, Sprigings D, Steeds RP, Jerosch-Herold M, Neubauer S, Prendergast B, Williams B, Zhang R, Hudson I, Squire IB, Ford I, Samani NJ, McCann GP. Comparison of exercise testing and CMR measured myocardial perfusion reserve for predicting outcome in asymptomatic aortic stenosis: the PRognostic Importance of MIcrovascular Dysfunction in Aortic Stenosis (PRIMID AS) Study. Eur Heart J. 2017 Apr 21;38(16):1222-1229. doi: 10.1093/eurheartj/ehx001. PMID: 28204448 PMCID: PMC5837288
  • Barton GR, Irvine L, Flather M, McCann GP, Curzen N, Gershlick AH; CvLPRIT Investigators. Economic Evaluation of Complete Revascularization for Patients with Multivessel Disease Undergoing Primary Percutaneous Coronary Intervention. Value Health. 2017 Jun;20(6):745-751. doi: 10.1016/j.jval.2017.02.002. Epub 2017 Mar 22. PMID: 28577691
  • McCann GP, Khan JN, Greenwood JP, Nazir S, Dalby M, Curzen N, Hetherington S, Kelly DJ, Blackman DJ, Ring A, Peebles C, Wong J, Sasikaran T, Flather M, Swanton H, Gershlick AH. Complete versus lesion-only primary pci: The randomized cardiovascular mr cvlprit substudy. Journal of the American College of Cardiology. 2015;66:2713-2724
  • Gershlick AH, Khan JN, Kelly DJ, Greenwood JP, Sasikaran T, Curzen N, Blackman DJ, Dalby M, Fairbrother KL, Banya W, Wang D, Flather M, Hetherington SL, Kelion AD, Talwar S, Gunning M, Hall R, Swanton H, McCann GP. Randomized trial of complete versus lesion-only revascularization in patients undergoing primary percutaneous coronary intervention for stemi and multivessel disease: The cvlprit trial. Journal of the American College of Cardiology. 2015;65:963-972
  • Khan JN, Razvi N, Nazir SA, Singh A, Masca NG, Gershlick AH, Squire I, McCann GP. Prevalence and extent of infarct and microvascular obstruction following different reperfusion therapies in st-elevation myocardial infarction. J Cardiovasc Magn Reson. 2014 May 27;16:38
  • Nazir SA, Khan JN, McCann GP. Free breathing motion-corrected t1 mapping for robust assessment of myocardial injury post myocardial infarction. Int J Cardiovasc Imaging. 2014 Jul 19
  • Singh A, Steadman CD, McCann GP. Advances in the understanding of the pathophysiology and management of aortic stenosis: Role of novel imaging techniques. Can J Cardiol. 2014 Sep;30(9):994-1003
  • Khan JN, Wilmot EG, Leggate M, Singh A, Yates T, Nimmo M, Khunti K, Horsfield MA, Biglands J, Clarysse P, Croisille P, Davies M, McCann GP. Subclinical diastolic dysfunction in young adults with type 2 diabetes mellitus: A multiparametric contrast-enhanced cardiovascular magnetic resonance pilot study assessing potential mechanisms. Eur Heart J Cardiovasc Imaging. 2014 Nov;15(11):1263-9
  • Singh A, Steadman CD, Khan JN, Horsfield MA, Bekele S, Nazir SA, Kanagala P, Masca NG, Clarysse P, McCann GP. Intertechnique agreement and interstudy reproducibility of strain and diastolic strain rate at 1.5 and 3 tesla: A comparison of feature-tracking and tagging in patients with aortic stenosis. J Magn Reson Imaging. 2014 Apr 3.
  • Fairbairn TA, Steadman CD, Mather AN, Motwani M, Blackman DJ, Plein S, McCann GP, Greenwood JP. Assessment of valve haemodynamics, reverse ventricular remodelling and myocardial fibrosis following transcatheter aortic valve implantation compared to surgical aortic valve replacement: A cardiovascular magnetic resonance study. Heart. 2013 Aug;99(16):1185-91
  • Devaux Y, Vausort M, McCann GP, Zangrando J, Kelly D, Razvi N, Zhang L, Ng LL, Wagner DR, Squire IB. Microrna-150: A novel marker of left ventricular remodeling after acute myocardial infarction. Circ Cardiovasc Genet. 2013 Jun;6(3):290-8
  • Devaux Y, Vausort M, McCann GP, Kelly D, Collignon O, Ng LL, Wagner DR, Squire IB. A panel of 4 micrornas facilitates the prediction of left ventricular contractility after acute myocardial infarction. PLoS One. 2013 Aug 13;8(8):e70644
  • Steadman CD, Jerosch-Herold M, Grundy B, Rafelt S, Ng LL, Squire IB, Samani NJ, McCann GP. Determinants and functional significance of myocardial perfusion reserve in severe aortic stenosis. JACC Cardiovascular imaging. 2012;5:182-189


Full list of papers for 2015-2009

Papers before 2009


My research programme is focused on better understanding of cardiovascular disease in vivo, developing and assessing novel treatments and implementing large multi-centre trials that change clinical practice.

I have been successful in attracting external funding with grant income over £8M (>£4.5M as PI or lead applicant).

I have published three original research papers in one of the world leading cardiology journals, JACC, in the last 18 months.

I have extensive experience in clinical trials in stable and unstable coronary artery disease syndromes.

I led the recently published CvLPRIT CMR study and I am the UK Chief investigator for the Bayer Sponsored GADACAD 1 study, an International multi-centre diagnostic accuracy study.

I am a PI for the 2 largest trials of cardiac MRI to date (MR-INFORM, the BHF funded CEMARC-2) and a named collaborator in the $15M NIH funded study of CMR to phenotype and risk stratify 2750 00 hypertrophic cardiomyopathy patients.

I have overseen the core lab CMR analysis for four Nationally funded trials.

Share this page: